MAILLY, F and XU, CF and XHIGNESSE, M and LUSSIERCACAN, S and TALMUD, PJ and DAVIGNON, J and HUMPHRIES, SE and NESTRUCK, AC (1991) CHARACTERIZATION OF A NEW APOLIPOPROTEIN-E5 VARIANT DETECTED IN 2 FRENCH-CANADIAN SUBJECTS. J LIPID RES , 32 (4) 613 - 620.
We have found a novel apoE5 mutation, using isoelectric focusing (IEF), in two apparently unrelated French-Canadian subjects. Co-dominant inheritance was demonstrated in the family of the first proband, a healthy male subject. The presence of the apoE5 form was not associated with lipid abnormalities or cardiovascular disease in this family. The second proband was a hyperlipidemic female patient suffering from angina, with no informative relatives available for study. In both individuals, monoclonal antibody studies demonstrated that the mutation was associated with the loss of two overlapping epitopes at the amino terminus of the protein. Cysteamine treatment of the very low density lipoproteins indicated that the mutant apoE contained only one cysteine residue, suggesting that apoE3 was the parental form. Two-dimensional electrophoresis suggested that the mutated protein had a slightly lower molecular weight (by 1-2 kDa). However, DNA sequencing of the third exon of the apoE gene in both probands revealed a single G to A substitution at the 48th nucleotide, changing the amino acid at position 13 from glutamic acid to lysine. These results were confirmed by oligo melting experiments with allele-specific probes in relatives of the probands. The study of this apoE variant should provide additional insight into the structure-function relationship of apoE.
|Title:||CHARACTERIZATION OF A NEW APOLIPOPROTEIN-E5 VARIANT DETECTED IN 2 FRENCH-CANADIAN SUBJECTS|
|Open access status:||An open access publication|
|Keywords:||DNA SEQUENCE, OLIGONUCLEOTIDE PROBES, MONOCLONAL ANTIBODIES, EPITOPE LOSS, POLYMERASE CHAIN-REACTION, RECEPTOR-BINDING DOMAIN, HUMAN-E APOPROTEIN, III HYPERLIPOPROTEINEMIA, FAMILIAL DYSBETALIPOPROTEINEMIA, OLIGONUCLEOTIDE PROBES, LIPOPROTEIN RECEPTORS, MONOCLONAL-ANTIBODY, E POLYMORPHISM, APO-E|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science|
Archive Staff Only: edit this record